Allist(SH:688578) Shang Hai Zheng Quan Bao·2025-09-02 19:29Core Viewpoint - Shanghai Ailis Pharmaceutical Technology Co., Ltd. has announced a cash dividend of 0.40 RMB per share (including tax) for the first half of 2025, totaling 180 million RMB to be distributed to shareholders [2][4]. Distribution Plan - The dividend distribution is based on a total share capital of 450 million shares, with a cash dividend of 0.40 RMB per share, amounting to a total distribution of 180 million RMB (including tax) [4]. - The distribution is authorized by the company's board of directors following the approval of the 2024 annual general meeting held on May 14, 2025 [2][3]. Distribution Implementation - The cash dividends will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the registration date [3]. - Shareholders who have not completed designated trading will have their dividends held by the China Securities Depository and Clearing Corporation until they complete the necessary trading [6]. Taxation Details - For individual shareholders holding unrestricted circulating shares, dividends are subject to different tax treatments based on the holding period. Those holding shares for over one year are exempt from individual income tax, while those holding for one year or less will have taxes calculated upon the sale of shares [8]. - Qualified Foreign Institutional Investors (QFII) will have a 10% withholding tax applied, resulting in a net dividend of 0.36 RMB per share [9]. - For Hong Kong investors, a similar 10% withholding tax applies, leading to a net dividend of 0.36 RMB per share [9]. - Other corporate shareholders are responsible for their own tax declarations, receiving a gross dividend of 0.40 RMB per share [10].